Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.
about
Peptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal models[A meta-analysis of platinum plus docetaxel or vinorelbine in the first-line treatment of advanced non-small cell lung cancer].The efficacy of bevacizumab compared with other targeted drugs for patients with advanced NSCLC: a meta-analysis from 30 randomized controlled clinical trials.Trans-bronchoscopy with implantation of (125)I radioactive seeds in patients with pulmonary atelectasis induced by lung cancer.Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR MutationsQuality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trialsA pilot study of extremely low-frequency magnetic fields in advanced non-small cell lung cancer: Effects on survival and palliation of general symptoms.Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer.Re-challenge chemotherapy with gemcitabine plus carboplatin in patients with non-small cell lung cancer.The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer.The impact of tumor size change after target therapy on survival: analysis of patients enrolled onto three clinical trials of advanced NSCLC from one institution.Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer.Quality of life of lung cancer patients receiving outpatient chemotherapy[The cost-effectiveness analysis of gefitinib or erlotinib in the treatment of advanced EGFR mutant non-small cell lung cancer patients].
P2860
Q28538039-022E0D96-7D82-494C-B613-0930EC972D91Q33414806-70919EF2-1469-45DC-A15F-39CA9CCB0F5AQ34685531-0D66A710-98F6-46CC-8A18-AEAD85CC980AQ35803837-EC5F1F76-8FDB-42FA-B91D-C6A7286ED6DAQ36187075-A055DADF-65B2-4F2A-96A7-38418B58A16CQ36224556-2B9349CC-5C0B-445F-8671-0653B4776507Q36403448-7C511978-C792-4508-8B3E-5396112703F0Q36455063-713927A1-F89A-4754-A54C-D41EEE6856DDQ37353925-41925EA0-3222-4E25-B3B8-DE846F7B8BE6Q37603638-AABE1223-9365-4E29-A732-2B5285981138Q38061626-8A783049-3028-4AD7-891E-18844193E024Q39192389-DFB99FA6-EB5F-402E-B6A5-A284B2B07790Q41882778-3568A74C-D8A8-4CAB-93E2-EB2BA53EC777Q55465371-301D90F9-BB80-40CE-8162-E458DEBC267D
P2860
Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.
@ast
Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.
@en
type
label
Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.
@ast
Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.
@en
prefLabel
Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.
@ast
Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.
@en
P1433
P1476
Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease
@en
P2093
Silvia Novello
P304
P577
2003-03-01T00:00:00Z